Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Haleon declared a $0.1307 quarterly dividend, yielding 251%, with strong earnings support and a sustainable payout ratio.
Haleon (NYSE: HLN) announced a quarterly dividend of $0.1307 per share, payable on May 14, 2026, to shareholders of record as of April 10, with an ex-dividend date of the same day.
The dividend yields 251% based on the current stock price, supported by a 20.4% payout ratio, indicating strong earnings coverage.
Analysts project next year’s earnings at $0.49 per share, suggesting a sustainable future payout ratio of 22.4%.
The stock rose $0.29 to $10.73 on Thursday, with trading volume below average.
Haleon, a UK-based consumer healthcare company formed in 2022, offers over-the-counter medicines, oral care, vitamins, and symptom relief products under brands like Advil, Centrum, and Sensodyne.
It has a market cap of $47.76 billion, a P/E ratio of 27.50, and a debt-to-equity ratio of 0.48.
Haleon declaró un dividendo trimestral de $0.1307, con un rendimiento del 251%, con un fuerte respaldo a las ganancias y una tasa de pago sostenible.